Sana Biotechnology shares are trading higher after the company announced a strategic collaboration with Mayo Clinic to advance development of SC451. Also, the company sold 7.5 million shares at $3.33 per share for $25 million to Mayo Clinic.

SANA

IBBQ

LABU

SBIO

<p>Sana Biotechnology shares are trading higher after the company announced a strategic collaboration with Mayo Clinic to advance development of SC451. Also, the company sold 7.5 million shares at $3.33 per share for $25 million to Mayo Clinic.</p>

benzinga_article

Sana Biotechnology

Invesco Nasdaq Biotechnology ETF

Direxion S&P Biotech Bull 3X

Invesco Biotechnology & Genome ETF

First Trust NYSE Arca Biotech Index Fd

SPDR S&P Biotech

ALPS Medical Breakthrough

VanEck Biotech ETF

Proshares Ultra Nasdaq Biotech

iShares Biotechnology ETF

News